131 related articles for article (PubMed ID: 24791589)
1. Novel renin inhibitors containing a non-peptide aminoalkanoyl moiety at P1-P1' position.
Winiecka I; Marszałek D; Goldnik A; Jaworski P; Mazurek AP
Pharmazie; 2014 Apr; 69(4):263-70. PubMed ID: 24791589
[TBL] [Abstract][Full Text] [Related]
2. New renin inhibitors containing phenylalanylhistidyl-gamma-amino acid derivatives in P3 - P1' position.
Winiecka I; Marszałek D; Goldnik A; Jaworski P; Mazurek AP
Acta Pol Pharm; 2014; 71(1):59-69. PubMed ID: 24779195
[TBL] [Abstract][Full Text] [Related]
3. Novel renin inhibitors containing derivatives of N-alkylleucyl-β-hydroxy-γ-amino acids.
Winiecka I; Jaworski P; Mazurek AP; Marszałek D; Goldnik A; Sokulski D
J Pept Sci; 2016 Feb; 22(2):106-15. PubMed ID: 26780837
[TBL] [Abstract][Full Text] [Related]
4. New renin inhibitors containing pseudodipeptidic units in P3-P2 and P1-P1' positions.
Paruszewski R; Jaworski P; Bodnar M; Dudkiewicz-Wilczyńska J; Roman I
Chem Pharm Bull (Tokyo); 2005 Oct; 53(10):1305-9. PubMed ID: 16204988
[TBL] [Abstract][Full Text] [Related]
5. New potential renin inhibitors with dipeptide replacements in the molecule.
Winiecka I; Dudkiewicz-Wilczyńska J; Roman I; Paruszewski R
Acta Pol Pharm; 2010; 67(4):367-74. PubMed ID: 20635532
[TBL] [Abstract][Full Text] [Related]
6. Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutions.
Sawyer TK; Pals DT; Mao B; Staples DJ; de Vaux AE; Maggiora LL; Affholter JA; Kati W; Duchamp D; Hester JB
J Med Chem; 1988 Jan; 31(1):18-30. PubMed ID: 3275777
[TBL] [Abstract][Full Text] [Related]
7. Renin inhibitors containing new P1-P1' dipeptide mimetics with heterocycles in P1'.
Raddatz P; Jonczyk A; Minck KO; Rippmann F; Schittenhelm C; Schmitges CJ
J Med Chem; 1992 Sep; 35(19):3525-36. PubMed ID: 1404233
[TBL] [Abstract][Full Text] [Related]
8. Renin inhibitors based on novel dipeptide analogues. Incorporation of the dehydrohydroxyethylene isostere at the scissile bond.
Kempf DJ; de Lara E; Stein HH; Cohen J; Plattner JJ
J Med Chem; 1987 Nov; 30(11):1978-83. PubMed ID: 3312604
[TBL] [Abstract][Full Text] [Related]
9. Renin inhibitors containing statine and 6-aminohexanoic acid. Part III.
Paruszewski R; Tautt J; Dudkiewicz J
Pol J Pharmacol; 1993; 45(1):75-82. PubMed ID: 8401762
[TBL] [Abstract][Full Text] [Related]
10. Renin inhibitors containing conformationally restricted P1-P1' dipeptide mimetics.
Williams PD; Perlow DS; Payne LS; Holloway MK; Siegl PK; Schorn TW; Lynch RJ; Doyle JJ; Strouse JF; Vlasuk GP
J Med Chem; 1991 Mar; 34(3):887-900. PubMed ID: 2002469
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of stromelysin-1 (MMP-3) by P1'-biphenylylethyl carboxyalkyl dipeptides.
Esser CK; Bugianesi RL; Caldwell CG; Chapman KT; Durette PL; Girotra NN; Kopka IE; Lanza TJ; Levorse DA; MacCoss M; Owens KA; Ponpipom MM; Simeone JP; Harrison RK; Niedzwiecki L; Becker JW; Marcy AI; Axel MG; Christen AJ; McDonnell J; Moore VL; Olszewski JM; Saphos C; Visco DM; Hagmann WK
J Med Chem; 1997 Mar; 40(6):1026-40. PubMed ID: 9083493
[TBL] [Abstract][Full Text] [Related]
12. New renin inhibitors with pseudodipeptidic units in P(1)-P(1') and P(2')-P(3') positions.
Paruszewski R; Jaworski P; Winiecka I; Tautt J; Dudkiewicz J
Chem Pharm Bull (Tokyo); 2002 Jun; 50(6):850-3. PubMed ID: 12045347
[TBL] [Abstract][Full Text] [Related]
13. New renin inhibitors with hydrophilic C-terminus.
Paruszewski R; Jaworski P; Winiecka I; Tautt J; Dudkiewicz J
Pharmazie; 1999 Feb; 54(2):102-6. PubMed ID: 10084156
[TBL] [Abstract][Full Text] [Related]
14. Enzymatically stable renin inhibitors containing statine and 6 aminohexanoic acid. Part IV.
Paruszewski R; Jaworski P; Tautt J; Dudkiewicz J
Boll Chim Farm; 1994 May; 133(5):301-8. PubMed ID: 8068237
[TBL] [Abstract][Full Text] [Related]
15. Design of rat renin inhibitory peptides.
Hui KY; Holtzman EJ; Quinones MA; Hollenberg NK; Haber E
J Med Chem; 1988 Sep; 31(9):1679-86. PubMed ID: 3045320
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and evaluation of matrix metalloprotease inhibitors bearing cyclopropane-derived peptidomimetics as P1' and P2' replacements.
Reichelt A; Gaul C; Frey RR; Kennedy A; Martin SF
J Org Chem; 2002 Jun; 67(12):4062-75. PubMed ID: 12054939
[TBL] [Abstract][Full Text] [Related]
17. Orally potent human renin inhibitors derived from angiotensinogen transition state: design, synthesis, and mode of interaction.
Iizuka K; Kamijo T; Harada H; Akahane K; Kubota T; Umeyama H; Ishida T; Kiso Y
J Med Chem; 1990 Oct; 33(10):2707-14. PubMed ID: 2120440
[TBL] [Abstract][Full Text] [Related]
18. Substrate specificity of porcine renin: P1', P1, and P3 residues of renin substrates are crucial for activity.
Wang W; Liang TC
Biochemistry; 1994 Dec; 33(48):14636-41. PubMed ID: 7981226
[TBL] [Abstract][Full Text] [Related]
19. Novel renin inhibitors containing (2S,3S,5S)-2-amino-1-cyclohexyl-6-methyl-3,5-heptanediol fragment as a transition-state mimic at the P1-P1' cleavage site.
Yamada Y; Ando K; Ikemoto Y; Tada H; Shirakawa E; Inagaki E; Shibata S; Nakamura I; Hayashi Y; Ikegami K; Uchida I
Chem Pharm Bull (Tokyo); 1997 Oct; 45(10):1631-41. PubMed ID: 9353891
[TBL] [Abstract][Full Text] [Related]
20. Renin inhibitors. Syntheses of subnanomolar, competitive, transition-state analogue inhibitors containing a novel analogue of statine.
Boger J; Payne LS; Perlow DS; Lohr NS; Poe M; Blaine EH; Ulm EH; Schorn TW; LaMont BI; Lin TY
J Med Chem; 1985 Dec; 28(12):1779-90. PubMed ID: 3906131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
